查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679370

核酸甲基化市场规模、份额、趋势分析报告：按产品/服务、类型、技术、应用、最终用途、地区、细分预测，2025-2030 年

Nucleic Acid Methylation Market Size, Share & Trends Analysis Report By Product & Services (Kits & Reagents, Enzymes), By Type (DNA Methylation, RNA Methylation), By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

核酸甲基化市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，全球核酸甲基化市场预计到 2030 年将达到 77.7 亿美元，预测期内的复合年增长率为 14.69%。

这一市场受到早期疾病检测需求的不断增长、测序技术的进步以及精准医疗的日益普及的推动。对錶观遗传学、癌症诊断和神经系统疾病的研究日益增多，推动了市场扩张。人工智慧主导的生物资讯学、经济高效的NGS和质谱分析正在提高资料分析和效率。此外，製药和生物技术公司不断增加的投资以及政府对錶观遗传学研究的资助正在刺激创新。药物研发、个人化医疗和非侵入性诊断领域的应用不断扩大，进一步促进了市场的成长。

COVID-19 疫情加速了市场的发展，增加了对病毒表观遗传学、免疫反应和生物标记发现的研究。这推动了对先进测序技术、人工智慧主导的资料分析和精准医疗的需求。此外，政府资金和製药公司对分子诊断和药物开发的投资不断增加，进一步推动了基于甲基化的研究和临床应用。这些因素正在推动市场的成长，预计在预测期内市场将呈指数级增长。

此外，人工智慧的整合有望透过增强资料分析、改善生物标记发现和简化定序工作流程来推动市场成长。人工智慧生物资讯学将能够更快、更准确地解释甲基化模式，支援早期疾病检测和个人化医疗。此外，人工智慧自动化将降低研究成本、提高效率、加速药物发现，进一步促进市场扩张。预计这将对预测期内的市场成长产生积极影响。

高成本和技术复杂性给市场带来了重大挑战。先进的定序平台、生物资讯工具和甲基化检测需要大量投资，因此小型实验室和新兴市场难以获得它们。此外，对熟练人力、高级资料分析和昂贵试剂的需求进一步增加了营运成本。儘管自动化和人工智慧主导的生物资讯解决方案的整合提高了效率，但可负担性仍然是广泛采用的障碍，阻碍了预测期内的市场成长。

核酸甲基化市场报告重点

  • 2024 年，套件和试剂领域占据最大的市场占有率，为 34.89%，这得益于其在甲基化分析中的广泛应用、对錶观遗传研究的不断增长的需求、测序技术的进步以及对经济高效且高度准确的诊断解决方案的需求。另一方面，预计服务业在预测期内将以最快的复合年增长率成长。
  • DNA 甲基化领域在 2024 年占据了最大的市场占有率，因为它在疾病诊断、癌症研究和药物开发中发挥着至关重要的作用。采用 DNA 甲基化生物标记进行早期检测、定序技术的进步以及对錶观遗传学研究的投资增加进一步促进了市场主导地位。另一方面，RNA甲基化预计在预测期内以最快的复合年增长率增长。
  • 2024 年，次世代定序 (NGS) 领域预计将引领技术市场并以最快的复合年增长率 (2025-2030) 成长，这得益于其在分析 DNA 和 RNA 甲基化模式方面的高准确性、可扩展性和效率。癌症研究、表观遗传学研究和精准医疗中越来越多的应用、人工智慧生物资讯学的进步以及测序成本的下降正在推动这项技术的快速发展。预计亚硫酸氢盐测序和基于 PCR 的技术领域将在预测期内显着增长。
  • 药物发现和个人化医疗领域预计将在 2024 年占据应用市场的主导地位，这得益于其在分析 DNA 和 RNA 甲基化模式方面的高准确性、可扩展性和效率。癌症研究、表观遗传学研究和精准医疗的应用日益广泛、人工智慧生物资讯学的进步以及测序成本的下降正在推动这一领域的快速增长。另一方面，临床诊断预计在预测期内将以最快的复合年增长率成长。
  • 由于在药物发现、生物标记研究和精准医疗方面投入了大量资金，製药和生物技术公司部门在 2024 年占据了终端市场主导地位。基于甲基化的技术在标靶治疗开发中的应用日益广泛，再加上定序和人工智慧主导的资料分析的进步，进一步加强了其市场主导。另一方面，预计医院和诊断实验室在预测期内将以最快的复合年增长率成长。
  • 预计到 2024 年，北美地区将占据市场主导地位，占有 40.46% 的份额，这得益于对錶观遗传学研究的强劲投资、先进的医疗基础设施以及精准医疗的广泛应用。主要生物技术和製药公司的存在，以及对基于甲基化的诊断的监管支持，进一步推动了该地区市场的成长。预计亚太地区在预测期内的复合年增长率最快。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 核酸甲基化市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 核酸甲基化市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影响分析

第四章核酸甲基化市场：按产品/服务的估计和趋势分析

  • 产品/服务细分仪表板
  • 全球核酸甲基化市场产品与服务变化分析
  • 2018-2030年全球核酸甲基化市场规模及趋势分析（依产品及服务）
  • 套件和试剂
  • 酵素
  • 服务
  • 设备和软体
  • 耗材

第五章核酸甲基化市场：按类型估计和趋势分析

  • 类型细分仪表板
  • 全球核酸甲基化市场类型变化分析
  • 2018-2030年全球核酸甲基化市场规模及趋势分析（依类型）
  • DNA甲基化
  • RNA甲基化

第六章核酸甲基化市场：依技术、估计和趋势分析

  • 技术细分仪表板
  • 全球核酸甲基化市场技术变迁分析
  • 2018-2030年全球核酸甲基化市场规模及趋势分析（依技术）
  • 新一代定序（NGS）
  • 亚硫酸氢盐测序和基于PCR的技术
  • 基于微阵列的甲基化分析
  • 质谱法
  • 基于杂合反应和基于抗体的检测

第七章核酸甲基化市场：应用预测与趋势分析

  • 应用程式细分仪表板
  • 全球核酸甲基化市场应用变化分析
  • 2018-2030年全球核酸甲基化市场规模及应用趋势分析
  • 药物研发与个人化医疗
  • 临床诊断
  • 其他的

第八章核酸甲基化市场：依最终用途的估计和趋势分析

  • 最终用途细分仪表板
  • 全球核酸甲基化市场最终用途变化分析
  • 2018-2030年全球核酸甲基化市场规模及最终用途趋势分析
  • 製药和生物技术公司
  • 学术研究所
  • 医院和诊断实验室

第 9 章核酸甲基化市场：按产品/服务、类型、技术、应用、最终用途、区域、估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • New England Biolabs
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Abcam plc
    • Agilent Technologies Inc.
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • QIAGEN
    • Exact Sciences Corporation
    • Diagenode Diagnostics SA
Product Code: GVR-4-68040-524-6

Nucleic Acid Methylation Market Growth & Trends:

The global nucleic acid methylation market is anticipated to reach USD 7.77 billion by 2030 and is projected to grow at a CAGR of 14.69% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing demand for early disease detection, advancements in sequencing technologies, and growing adoption of precision medicine. Rising research in epigenetics, cancer diagnostics, and neurological disorders is fueling market expansion. AI-driven bioinformatics, cost-effective NGS, and mass spectrometry are enhancing data analysis and efficiency. In addition, increasing investments from pharmaceutical and biotech companies, along with government funding for epigenetics research, are accelerating innovation. Expanding applications in drug discovery, personalized medicine, and non-invasive diagnostics further contribute to market growth.

The COVID-19 pandemic accelerated the market by increasing research in viral epigenetics, immune response, and biomarker discovery. It drove demand for advanced sequencing technologies, AI-driven data analysis, and precision medicine. In addition, increased government funding and pharmaceutical investments in molecular diagnostics and drug development further boosted the adoption of methylation-based research and clinical applications. These factors have propelled the growth of the market and are anticipated to propel exponentially over the forecast period.

Moreover, AI integration is anticipated to propel market growth by enhancing data analysis, improving biomarker discovery, and streamlining sequencing workflows. AI-driven bioinformatics enables faster and more accurate interpretation of methylation patterns, supporting early disease detection and personalized medicine. In addition, AI-powered automation reduces research costs, increases efficiency, and accelerates drug discovery, further driving market expansion. Thereby expected to positively impact the growth of the market over the forecast period.

High costs and technical complexity pose significant challenges to the market. Advanced sequencing platforms, bioinformatics tools, and methylation assays require substantial investment, making them less accessible to smaller research labs and emerging markets. In addition, the need for highly skilled personnel, sophisticated data analysis, and expensive reagents further increases operational costs. The integration of automation and AI-driven bioinformatics solutions is improving efficiency, but affordability remains a barrier to widespread adoption, thereby hampering the growth of the market over the forecast period.

Nucleic Acid Methylation Market Report Highlights:

  • The kits & reagents segment held the largest market share of 34.89% in 2024 due to their widespread use in methylation analysis, growing demand for epigenetic research, advancements in sequencing technologies, and the need for cost-effective, high-precision diagnostic solutions. On the other hand, services are expected to grow at the fastest CAGR over the forecast period.
  • The DNA methylation segment held the largest market share in 2024 due to its crucial role in disease diagnostics, cancer research, and drug development. Growing adoption of DNA methylation biomarkers for early detection, advancements in sequencing technologies, and increasing investment in epigenetics research have further driven its market dominance. On the other hand, RNA methylation is expected to grow at the fastest CAGR over the forecast period.
  • In 2024, the next-generation sequencing (NGS) segment is expected to lead the technology market and grow at the fastest CAGR (2025-2030) due to its high accuracy, scalability, and efficiency in analyzing DNA and RNA methylation patterns. Increasing adoption in cancer research, epigenetics studies, and precision medicine, along with advancements in AI-driven bioinformatics and decreasing sequencing costs, are driving its rapid growth. The bisulfite sequencing & PCR-based techniques segment is expected to grow significantly over the forecast period.
  • In 2024, the drug discovery & personalized medicines segment is expected to dominate the application market due to its high accuracy, scalability, and efficiency in analyzing DNA and RNA methylation patterns. Increasing adoption in cancer research, epigenetics studies, and precision medicine, along with advancements in AI-driven bioinformatics and decreasing sequencing costs, are driving its rapid growth. On the other hand, clinical diagnostics are expected to grow at the fastest CAGR over the forecast period.
  • The pharmaceutical & biotechnological companies segment dominated the end use market in 2024 due to their significant investment in drug discovery, biomarker research, and precision medicine. The growing use of methylation-based technologies for developing targeted therapies, coupled with advancements in sequencing and AI-driven data analysis, has further strengthened their market leadership. On the other hand, hospitals & diagnostic laboratories are expected to grow at the fastest CAGR over the forecast period.
  • The North America region dominated the market with a 40.46% share in 2024, driven by strong investments in epigenetics research, advanced healthcare infrastructure, and widespread adoption of precision medicine. The presence of leading biotechnology and pharmaceutical companies, along with regulatory support for methylation-based diagnostics, has further fueled market growth in the region. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Type
    • 1.2.3. Technology
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Nucleic Acid Methylation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for epigenetic biomarkers
      • 3.2.1.2. RNA methylation as a drug target
      • 3.2.1.3. Advancements in high-throughput methylation analysis
      • 3.2.1.4. Government & private investments in epigenetics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs & technical complexity
  • 3.3. Nucleic Acid Methylation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Nucleic Acid Methylation Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Global Nucleic Acid Methylation Market Product & Services Movement Analysis
  • 4.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Instruments & Software
    • 4.7.1. Instruments & software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Consumables
    • 4.8.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Nucleic Acid Methylation Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Nucleic Acid Methylation Market Type Movement Analysis
  • 5.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. DNA Methylation
    • 5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. RNA Methylation
    • 5.5.1. RNA methylation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Nucleic Acid Methylation Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Global Nucleic Acid Methylation Market Technology Movement Analysis
  • 6.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 6.4. Next-Generation Sequencing (NGS)
    • 6.4.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Bisulfite Sequencing & PCR-based Techniques
    • 6.5.1. Bisulfite sequencing & pcr-based techniques market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Microarray-based Methylation Analysis
    • 6.6.1. Microarray-based methylation analysis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Mass Spectrometry
    • 6.7.1. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Hybridization-based & Antibody-based Detection
    • 6.8.1. Hybridization-based & antibody-based detection market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Nucleic Acid Methylation Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Nucleic Acid Methylation Market Application Movement Analysis
  • 7.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Drug Discovery & Personalized Medicines
    • 7.4.1. Drug discovery & personalized medicines market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinical Diagnostics
    • 7.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Nucleic Acid Methylation Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Nucleic Acid Methylation Market End Use Movement Analysis
  • 8.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Academic & Research Institutes
    • 8.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Hospitals & Diagnostic Laboratories
    • 8.6.1. Hospitals & diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Nucleic Acid Methylation Market: Regional Estimates & Trend Analysis by Product & Services, Type, Technology, Application, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Regulatory framework
      • 9.8.5.3. Competitive scenario
      • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. New England Biolabs
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Illumina Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Abcam plc
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Agilent Technologies Inc.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. F. Hoffmann-La Roche Ltd
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bio-Rad Laboratories, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Exact Sciences Corporation
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Diagenode Diagnostics S.A.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global nucleic acid methylation market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 6 Global nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 10 North America nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 11 North America nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 15 U.S. nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 16 U.S. nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 20 Canada nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 21 Canada nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 25 Mexico nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 26 Mexico nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Mexico nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 31 Europe nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 32 Europe nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Europe nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 36 Germany nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 37 Germany nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Germany nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 39 Germany nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 41 UK nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 42 UK nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 43 UK nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 44 UK nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 46 France nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 47 France nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 48 France nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 49 France nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Italy nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 52 Italy nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Italy nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 56 Spain nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 57 Spain nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Spain nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 61 Denmark nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 62 Denmark nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Denmark nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 66 Sweden nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 67 Sweden nucleic acid methylation market, by technology, 2018 - 2030 (USD Million
  • Table 68 Sweden nucleic acid methylation market, by application, 2018 - 2030 (USD Million
  • Table 69 Sweden nucleic acid methylation market, by end use, 2018 - 2030 (USD Million
  • Table 70 Norway nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 71 Norway nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 72 Norway nucleic acid methylation market, by technology, 2018 - 2030 (USD Million
  • Table 73 Norway nucleic acid methylation market, by application, 2018 - 2030 (USD Million
  • Table 74 Norway nucleic acid methylation market, by end use, 2018 - 2030 (USD Million
  • Table 75 Asia Pacific nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific nucleic acid methylation market, by technology, 2018 - 2030 (USD Million
  • Table 78 Asia Pacific nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific nucleic acid methylation market, by application, 2018 - 2030 (USD Million
  • Table 80 Asia Pacific nucleic acid methylation market, by end use, 2018 - 2030 (USD Million
  • Table 81 China nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 82 China nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 83 China nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 84 China nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 85 China nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 87 Japan nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 88 Japan nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Japan nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 90 Japan nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 92 India nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 93 India nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 94 India nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 95 India nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 97 South Korea nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 98 South Korea nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 99 South Korea nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 100 South Korea nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 102 Australia nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 103 Australia nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 104 Australia nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 105 Australia nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 107 Thailand nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 108 Thailand nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Thailand nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 110 Thailand nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 113 Latin America nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Latin America nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 115 Latin America nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 118 Brazil nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 119 Brazil nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Brazil nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 123 Argentina nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 124 Argentina nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Argentina nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 129 MEA nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 130 MEA nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 134 South Africa nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 144 UAE nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 145 UAE nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 146 UAE nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 149 Kuwait nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Kuwait nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Nucleic acid methylation market: Market outlook
  • Fig. 5 Nucleic acid methylation market: Segment outlook
  • Fig. 6 Nucleic acid methylation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Nucleic acid methylation market driver impact
  • Fig. 9 Nucleic acid methylation market restraint impact
  • Fig. 10 Nucleic acid methylation market: Product & services outlook and key takeaways
  • Fig. 11 Nucleic acid methylation market: Product & services movement analysis
  • Fig. 12 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Instruments & software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Nucleic acid methylation market: Type outlook and key takeaways
  • Fig. 18 Nucleic acid methylation market: Type movement analysis
  • Fig. 19 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 RNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Nucleic acid methylation market: Technology outlook and key takeaways
  • Fig. 22 Nucleic acid methylation market: Technology movement analysis
  • Fig. 23 Next-generation sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Bisulfite sequencing & PCR-based techniques market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 25 Microarray-based methylation analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Hybridization-based & antibody-based detection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Nucleic acid methylation market: Application outlook and key takeaways
  • Fig. 29 Nucleic acid methylation market: Application movement analysis
  • Fig. 30 Drug discovery & personalized medicines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Nucleic acid methylation market: End use outlook and key takeaways
  • Fig. 34 Nucleic acid methylation market: End use movement analysis
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Hospitals & diagnostic laboratories market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 38 Global nucleic acid methylation market: Regional outlook and key takeaways
  • Fig. 39 Global nucleic acid methylation market: Regional movement analysis
  • Fig. 40 North America nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 UAE nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)